Live Breaking News & Updates on Biosciences holdings inc

Stay updated with breaking news from Biosciences holdings inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Harmony Secures Rights to Develop Bioprojet's Orexin-2 Agonist

Harmony has entered into a licensing agreement to develop and commercialize TPM-1116, a selective oral orexin-2 receptor agonist. ....

France , United-states , American , French , America , Jean-charles-schwartz , Jeffreym-dayno , Harmony-biosciences-holdings-inc , Harmony-biosciences , Latin-american , Biosciences-holdings-inc , European-academies

Phase 3 Study of Pitolisant for Prader-Willi Syndrome Begins

The study will evaluate pitolisant for treating excessive daytime sleepiness and behavioral symptoms in patients with Prader-Willi syndrome. ....

Kumar-budur , Harmony-biosciences-holdings-inc , Drug-administration , Biosciences-holdings-inc , Orphan-drug , Harmony-biosciences ,

North American Morning Briefing : Nvidia Ignites -2- - 2024-02-22

Teck Declares Dividend of 12.5c; Board Authorized Up to $500M Share Buyback; Planned Repurchase Reflect Distribution in Respect of 30% of Proceeds From Minority Sale of Steelmaking-Coal Business to.
-February 22, 2024 at 06:20 am EST
- MarketScreener ....

Japan , Germany , Denbury , Devon , United-kingdom , France , Nippon , Gordon-haskett , Piper-sandler , Weekly-international , Armada-hoffler-properties , Palo-alto-networks-cut-to-neutral-from